IRIS
ZAPPAVIGNA, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.792
NA - Nord America 4.181
AS - Asia 3.042
SA - Sud America 369
AF - Africa 55
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.453
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 5.036
US - Stati Uniti d'America 4.127
SG - Singapore 1.030
IE - Irlanda 801
IT - Italia 683
CN - Cina 677
VN - Vietnam 443
HK - Hong Kong 362
BR - Brasile 321
GB - Regno Unito 259
DE - Germania 239
UA - Ucraina 230
KR - Corea 186
FR - Francia 138
SE - Svezia 92
FI - Finlandia 88
IN - India 86
JP - Giappone 73
GR - Grecia 72
TR - Turchia 54
CA - Canada 30
PL - Polonia 27
BG - Bulgaria 23
AR - Argentina 22
NL - Olanda 22
BE - Belgio 21
ZA - Sudafrica 21
AT - Austria 20
PK - Pakistan 20
BD - Bangladesh 17
ID - Indonesia 17
MX - Messico 17
ES - Italia 14
MA - Marocco 12
UZ - Uzbekistan 12
IR - Iran 10
AU - Australia 8
CO - Colombia 8
EC - Ecuador 8
IQ - Iraq 8
PH - Filippine 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
KE - Kenya 5
AZ - Azerbaigian 4
DZ - Algeria 4
EU - Europa 4
LT - Lituania 4
SN - Senegal 4
TW - Taiwan 4
AL - Albania 3
CH - Svizzera 3
CL - Cile 3
KZ - Kazakistan 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
VE - Venezuela 3
AM - Armenia 2
DK - Danimarca 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
JM - Giamaica 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
NR - Nauru 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PW - Palau 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
UG - Uganda 1
UY - Uruguay 1
Totale 15.453
Salva come PNG Salva come JPEG
Città #
Moscow 1.772
Dublin 801
San Jose 705
Chandler 517
Singapore 489
Santa Clara 448
Jacksonville 363
Hong Kong 358
Dallas 199
Seoul 175
Ashburn 160
Ho Chi Minh City 127
Hefei 117
Naples 111
New York 110
Caserta 98
Princeton 96
Beijing 94
Hanoi 89
Roxbury 83
Medford 73
Los Angeles 64
Bengaluru 62
Boardman 59
Bremen 58
Ann Arbor 54
Dong Ket 54
The Dalles 43
Munich 39
Des Moines 36
Cambridge 33
Wilmington 33
Aversa 31
Napoli 31
São Paulo 30
Helsinki 27
Orem 26
Nuremberg 25
Woodbridge 25
Mountain View 24
Da Nang 22
San Mateo 22
Milan 21
Brussels 20
Haiphong 19
Warsaw 17
Rome 15
Johannesburg 14
Frankfurt am Main 13
London 13
Rio de Janeiro 12
Amsterdam 11
Campodarsego 11
Tashkent 11
Guangzhou 10
Istanbul 10
San Nicola la Strada 10
Tokyo 10
Falkenstein 9
Jinan 9
Madrid 9
Memphis 9
Mexico City 9
San Felice A Cancello 9
Vienna 9
Atlanta 8
Biên Hòa 8
Boston 8
Denver 8
Houston 8
Jakarta 8
Piscataway 8
San Francisco 8
Thái Nguyên 8
Brooklyn 7
Changsha 7
Council Bluffs 7
Curitiba 7
Elora 7
Nanjing 7
Phoenix 7
Redwood City 7
Tianjin 7
Xi'an 7
Cagliari 6
Chicago 6
Columbus 6
Düsseldorf 6
Hillsboro 6
Montreal 6
Ningbo 6
Ninh Bình 6
Norwalk 6
Seregno 6
Stockholm 6
Thái Bình 6
Auburn Hills 5
Belo Horizonte 5
Bologna 5
Brno 5
Totale 8.297
Salva come PNG Salva come JPEG
Nome #
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure 218
Mitochondria as playmakers of apoptosis, autophagy and senescence 198
Dicrocoelium dendriticum induces autophagic vacuoles accumulation in human hepatocarcinoma cells 194
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 193
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 193
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 191
Effect of restriction vegan diet's on muscle mass, oxidative status, and myocytes differentiation: A pilot study 190
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. 188
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures 185
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 185
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. 183
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 183
A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells 181
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 181
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells 178
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 178
Anti-inflammatory drugs as anticancer agents 177
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 175
Valutazione in vitro degli effetti cardiotossici da 5-Fluorouracile per la prevenzione dei danni cardiovascolari negli operatori sanitari professionalmente esposti. [Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed]. 171
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 171
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 171
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. 166
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. 165
Chitosan-based polyelectrolyte complexes for doxorubicin and zoledronic acid combined therapy to overcome multidrug resistance 162
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 161
Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx 160
Immune cell infiltration and inflammatory landscape in primary brain tumours 156
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 156
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO 155
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 153
MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells 153
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 151
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 150
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 146
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress. 146
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 145
Transferrin-targeted nanoparticles containing zoledronic acid as a potential to inhibit glioblastoma growth 144
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 144
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine 144
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 143
Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomide 142
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma 142
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines. 141
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 140
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 140
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 140
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 140
The role of micrornas in development of colitis-associated colorectal cancer 139
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 138
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. 136
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 136
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. 135
Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer 134
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells 134
Emerging pathways as individualized therapeutic target of multiple myeloma. 134
Poly(ε-caprolactone)-poly(ethylene glycol) Tri-Block Copolymer as Quercetin Delivery System for Human Colorectal Carcinoma Cells: Synthesis, Characterization and In Vitro Study 131
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 130
Autophagic cell death: A new frontier in cancer research 130
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 129
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 126
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions 126
Characterization of KRAS Mutational Regression in Oligometastatic Patients 125
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 124
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 124
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 123
Interleukin 18: Friend or foe in cancer. 123
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 123
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 123
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? 122
CYR61 down-modulation induced by zoledronic acid impairs cell motility and sensitizes prostate cancer cells to docetaxel: A new anti-cancer strategy 122
Evolutionary conservation of a regulative pathway of erythropoiesis in Poikilothermic vertebrates 120
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. 120
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance. 120
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 119
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts 119
Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines 119
Measurement of autophagy by flow cytometry 119
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 119
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. 117
Long non-coding RNAs in cancer stem cells 116
Drug-drug interactions based on pharmacogenetic profile between highly active antiretroviral therapy and antiblastic chemotherapy in cancer patients with HIV infection 114
Erlotinib: early clinical development in brain cancer. 113
Testicular cancer from diagnosis to epigenetic factors 113
Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer 112
Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use 110
Stealth liposomes for the delivery of zoledronic acid into tumors enhance the anticancer activity of the drug 108
Zoledronic acid encapsulated in self-assembly pegylated nanoparticles as a new delivery system against brain tumors 107
Hepatocarcinoma: genetic and epigenetic features 106
UROTENSIN II RECEPTOR IS INVOLVED IN THE REGULATION OF MOTILITY OF PROSTATE ADENOCARCINOMA CELLS AND PREDICTS THE CLINICAL OUTCOME OF PROSTATE CANCER PATIENTS 105
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade 105
Protein kinase a detection in human urine samples 105
Ipilimumab for the treatment of metastatic prostate cancer 104
LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides. 104
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. 103
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. 103
Non-coding RNAs as a new dawn in tumor diagnosis 98
Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma 98
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. 96
CYR61 DOWN-MODULATION SENSITIZES PROSTATE CANCER CELLS TO ZOLEDRONIC ACID AND DOCETAXEL: A NEW ANTICANCER STRATEGY 96
Levofolene modulates apoptosis induced by 5-fluorouracil through autophagy inhibition: Clinical and occupational implications 95
Totale 14.019
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.505
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 0 0 0 0 0 0 70
2021/2022688 24 11 11 12 206 11 15 22 30 89 50 207
2022/20231.710 155 49 29 193 149 163 3 106 750 23 55 35
2023/2024740 72 32 54 37 202 93 19 20 12 5 51 143
2024/20251.914 17 46 8 99 287 301 233 178 285 185 158 117
2025/20268.890 341 441 550 337 694 4.661 564 630 238 235 186 13
Totale 15.835